Light microscopy, culture, molecular, and serologic methods for detection of herpes simplex virus

NW Anderson, BW Buchan… - Journal of clinical …, 2014 - Am Soc Microbiol
ABSTRACT Herpes simplex virus 1 (HSV-1) and 2 (HSV-2) cause a variety of human
diseases, ranging from acute to chronic and mild to severe. The absence of curative therapy …

[HTML][HTML] Tannic acid modified silver nanoparticles show antiviral activity in herpes simplex virus type 2 infection

P Orlowski, E Tomaszewska, M Gniadek, P Baska… - PloS one, 2014 - journals.plos.org
The interaction between silver nanoparticles and herpesviruses is attracting great interest
due to their antiviral activity and possibility to use as microbicides for oral and anogenital …

[HTML][HTML] Antiviral activity of tannic acid modified silver nanoparticles: potential to activate immune response in herpes genitalis

P Orłowski, A Kowalczyk, E Tomaszewska… - Viruses, 2018 - mdpi.com
(1) Background: Tannic acid is a plant-derived polyphenol showing antiviral activity mainly
because of an interference with the viral adsorption. In this work, we tested whether the …

Varicella-zoster virus CNS disease—viral load, clinical manifestations and sequels

A Persson, T Bergström, M Lindh, L Namvar… - Journal of clinical …, 2009 - Elsevier
BACKGROUND: Real-time polymerase chain reaction (PCR) analysis of cerebrospinal fluid
(CSF) samples has improved the diagnosis of varicella-zoster virus (VZV) infection of the …

[HTML][HTML] Multifunctional tannic acid/silver nanoparticle-based mucoadhesive hydrogel for improved local treatment of HSV infection: In vitro and in vivo studies

E Szymańska, P Orłowski, K Winnicka… - International journal of …, 2018 - mdpi.com
Mucoadhesive gelling systems with tannic acid modified silver nanoparticles were
developed for effective treatment of herpes virus infections. To increase nanoparticle …

The potential of currently unavailable herpes virus vaccines

J Rajčáni, F Bánáti, K Szenthe… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Despite overwhelming experimental work, there are no licensed vaccines
against the most frequent Alphaherpesviruses, namely herpes simplex virus 1 and 2 (HSV1 …

[HTML][HTML] An IKBKE variant conferring functional cGAS/STING pathway deficiency and susceptibility to recurrent HSV-2 meningitis

A Reyahi, M Studahl, MK Skouboe, S Fruhwürth… - JCI insight, 2023 - ncbi.nlm.nih.gov
The mechanisms underlying susceptibility to recurrent herpes simplex virus type 2 (HSV-2)
meningitis remain incompletely understood. In a patient experiencing multiple episodes of …

[HTML][HTML] Lactoferrin-functionalized noble metal nanoparticles as new antivirals for HSV-2 infection

M Krzyzowska, M Chodkowski, M Janicka, D Dmowska… - Microorganisms, 2022 - mdpi.com
(1) Background: Lactoferrin has been recognized as a potent inhibitor of human herpetic
viruses, such as herpes simplex type 1 (HSV-1) and 2 (HSV-2). In this work, we tested if …

[HTML][HTML] Assessment of the FilmArray ME panel in 4199 consecutively tested cerebrospinal fluid samples

J Lindström, K Elfving, M Lindh, J Westin… - Clinical Microbiology and …, 2022 - Elsevier
Objectives In central nervous system infections, early and correct management is of utmost
importance. Rapid syndromic panel testing can potentially provide valuable guidance. The …

[HTML][HTML] Epigallocatechin gallate-modified silver nanoparticles show antiviral activity against herpes simplex type 1 and 2

M Krzyzowska, M Janicka, M Chodkowski, M Patrycy… - Viruses, 2023 - mdpi.com
(1) Background: Epigallocatechin gallate (EGCG) has been recognized as a flavonoid
showing antiviral activity against various types of DNA and RNA viruses. In this work, we …